×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Infinity Pharmaceuticals Inc.. (INFI) NASDAQ

$0.02 - (-)

Market Cap: -

As of 09/29/23 12:00 AM EDT. Market closed.

(INFI)

Infinity Pharmaceuticals Inc.. (INFI)
NASDAQ

$0.02
- (-)

Market Cap: -

As of 09/29/23 12:00 AM EDT. Market closed.

Add to Portfolio

the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity’s programs arise from the integration of a broad range of research and development capabilities, including ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$689,585
CEO Compensation (Total)
$2.53M
URL
Address
1100 Massachusetts Ave Ste 4, Massachusetts, Cambridge, 02138-5241.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Adelene Perkins
CEO Compensation (Base)
$689,585
CEO Compensation (Total)
$2.53M
Address
1100 Massachusetts Ave Ste 4, Massachusetts, Cambridge, 02138-5241.
PRICE CHART FOR INFINITY PHARMACEUTICALS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.10
Previous Close
$0.02
Days Range
$0.01 - $0.02
52 week range
- - -
Volume
1,141,812
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
90,761,081
Open
$0.10
Previous Close
$0.02
Days Range
$0.01 - $0.02
52 week range
- - -
Volume
1,141,812
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
90,761,081
FINANCIAL STATEMENTS FOR INFINITY PHARMACEUTICALS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INFINITY PHARMACEUTICALS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Perkins Adelene QDirectorSep 12, 2023 Sale$0.07410,19628,7141,175,291Sep 12, 2023, 06:20 PM
Peluso StephaneChief Scientific OfficerAug 02, 2022 Sale$0.6614,9949,93237,052Aug 04, 2022, 06:26 PM
EVNIN ANTHONY BDirectorJun 16, 2022 Option Exercise$0.6846,37831,491215,403Jun 16, 2022, 09:29 PM
SCHWARTZ BRIANDirectorJun 16, 2022 Option Exercise$0.6830,91920,99430,919Jun 16, 2022, 08:32 PM
BEIER DAVID WDirectorJun 10, 2021 Option Exercise$3.433,06110,4998,775Jun 11, 2021, 04:17 PM
BVF PARTNERS L P/IL10% OwnerFeb 11, 2021 Sale$5.372,260,08512,133,4924,448,421Feb 16, 2021, 04:35 PM
BVF PARTNERS L P/IL10% OwnerJan 22, 2021 Sale$4.145,848,52024,205,8555,663,912Jan 26, 2021, 05:27 PM
EVNIN ANTHONY BDirectorJun 13, 2019 Option Exercise$1.6013,12521,000143,138Jun 14, 2019, 04:06 PM
Berkowitz JeffreyDirectorJun 13, 2019 Option Exercise$1.6026,25042,00085,238Jun 14, 2019, 04:05 PM
BVF PARTNERS L P/IL10% OwnerDec 13, 2018 Buy$1.20175,000209,9128,485,575Dec 17, 2018, 07:40 PM
BVF PARTNERS L P/IL10% OwnerNov 28, 2018 Buy$1.30100,000130,0006,510,597Nov 30, 2018, 06:28 PM
BVF PARTNERS L P/IL10% OwnerNov 21, 2018 Buy$1.354,7006,3458,431,114Nov 21, 2018, 05:57 PM
BVF PARTNERS L P/IL10% OwnerNov 19, 2018 Buy$1.371,465,1262,005,0768,426,995Nov 21, 2018, 05:57 PM
BVF PARTNERS L P/IL10% OwnerNov 14, 2018 Buy$1.34210,250281,7357,591,400Nov 15, 2018, 08:07 PM
BVF PARTNERS L P/IL10% OwnerNov 13, 2018 Buy$1.35604,208815,6817,474,110Nov 15, 2018, 08:07 PM
BVF PARTNERS L P/IL10% OwnerNov 15, 2018 Buy$1.3591,474123,4907,643,800Nov 15, 2018, 08:07 PM
Perkins Adelene QChief Executive OfficerOct 01, 2018 Sale$2.825,00014,100609,561Oct 02, 2018, 04:30 PM
Kutok JefferyChief Scientific OfficerAug 16, 2018 Sale$2.006,13312,2660Aug 17, 2018, 04:05 PM
Kutok JefferyChief Scientific OfficerAug 15, 2018 Sale$2.018,18016,4216,133Aug 17, 2018, 04:05 PM
Kutok JefferyChief Scientific OfficerJun 22, 2018 Sale$2.0014,31328,69514,313Jun 25, 2018, 05:00 PM
BVF PARTNERS L P/IL10% OwnerJun 19, 2018 Buy$1.653,516,5605,802,3247,202,101Jun 21, 2018, 06:57 PM
BVF PARTNERS L P/IL10% OwnerJun 21, 2018 Buy$1.65425,531702,1267,432,656Jun 21, 2018, 06:57 PM
Berkowitz JeffreyDirectorJun 12, 2018 Option Exercise$1.7522,85740,00058,988Jun 14, 2018, 08:35 AM
SMITH IAN FDirectorJun 12, 2018 Option Exercise$1.7522,85740,00045,845Jun 14, 2018, 08:34 AM
EVNIN ANTHONY BDirectorJun 12, 2018 Option Exercise$1.7511,42819,999130,013Jun 14, 2018, 08:33 AM
BEIER DAVID WDirectorJun 12, 2018 Option Exercise$1.755,71410,0005,714Jun 14, 2018, 08:30 AM
BVF PARTNERS L P/IL10% OwnerApr 09, 2018 Buy$1.90500,000950,0004,738,476Apr 11, 2018, 06:01 PM
BVF PARTNERS L P/IL10% OwnerApr 10, 2018 Buy$2.001,010,0002,020,0005,285,341Apr 11, 2018, 06:01 PM
Perkins Adelene QChief Executive OfficerMar 05, 2018 Sale$2.785,00013,890607,252Mar 07, 2018, 04:22 PM
BLOCH LAWRENCE EPresidentDec 06, 2017 Buy$1.81500,000905,000580,944Dec 07, 2017, 09:11 AM
BVF PARTNERS L P/IL10% OwnerOct 04, 2017 Buy$1.28653,449839,0294,509,785Oct 05, 2017, 08:07 PM
BVF PARTNERS L P/IL10% OwnerOct 03, 2017 Buy$1.24946,5971,169,0474,154,704Oct 05, 2017, 08:07 PM
Berkowitz JeffreyDirectorMay 25, 2017 Option Exercise$1.745,74710,00036,131May 26, 2017, 08:28 AM
EVNIN ANTHONY BDirectorMay 25, 2017 Option Exercise$1.7411,49420,000118,585May 26, 2017, 08:26 AM
SMITH IAN FDirectorMay 25, 2017 Option Exercise$1.7422,98839,99922,988May 26, 2017, 08:23 AM
VENUTI MICHAEL CDirectorMar 17, 2017 Sale$3.486,25021,75050,000Mar 20, 2017, 04:10 PM
BVF PARTNERS L P/IL10% OwnerJan 03, 2017 Buy$1.344,3795,8673,631,103Jan 05, 2017, 05:30 PM
BVF PARTNERS L P/IL10% OwnerDec 30, 2016 Buy$1.343,5534,7603,629,958Dec 30, 2016, 05:37 PM
BVF PARTNERS L P/IL10% OwnerDec 28, 2016 Buy$1.34738,848986,8053,627,610Dec 30, 2016, 05:37 PM
BVF PARTNERS L P/IL10% OwnerDec 19, 2016 Buy$1.36198,264269,3223,214,238Dec 20, 2016, 06:26 PM
BVF PARTNERS L P/IL10% OwnerDec 16, 2016 Buy$1.28434,656556,3603,106,036Dec 20, 2016, 06:26 PM
BVF PARTNERS L P/IL10% OwnerDec 20, 2016 Buy$1.3522,00129,8093,225,884Dec 20, 2016, 06:26 PM
KANGO SUJAYChief Commercial OfficerDec 13, 2016 Sale$1.2749,99163,25950,292Dec 14, 2016, 05:16 PM
KANGO SUJAYChief Commercial OfficerDec 12, 2016 Sale$1.3025,00932,61250,590Dec 14, 2016, 05:16 PM
BVF PARTNERS L P/IL10% OwnerDec 01, 2016 Buy$1.18148,894176,3652,838,645Dec 02, 2016, 05:50 PM
BVF PARTNERS L P/IL10% OwnerDec 02, 2016 Buy$1.1952,50062,4802,869,643Dec 02, 2016, 05:50 PM
EVNIN ANTHONY BDirectorJun 17, 2016 Option Exercise$1.5213,15719,999107,091Jun 21, 2016, 05:53 PM
LANDER ERIC SDirectorJun 17, 2016 Option Exercise$1.526,5789,99980,319Jun 21, 2016, 05:53 PM
Berkowitz JeffreyDirectorJun 17, 2016 Option Exercise$1.5226,31539,99930,384Jun 21, 2016, 05:52 PM
LANDER ERIC SDirectorSep 01, 2015 Option Exercise$8.602,03417,49273,741Sep 03, 2015, 04:17 PM
EVNIN ANTHONY BDirectorSep 01, 2015 Option Exercise$8.602,03417,49293,934Sep 03, 2015, 04:16 PM
Berkowitz JeffreyDirectorSep 01, 2015 Option Exercise$8.604,06934,9934,069Sep 03, 2015, 04:15 PM
Perkins Adelene QPresident & CEOJun 25, 2015 Sale$10.935,00054,650359,432Jun 26, 2015, 04:15 PM
Palombella Vito J.Chief Scientific OfficerJun 15, 2015 Sale$10.974,73751,965868Jun 16, 2015, 04:15 PM
Perkins Adelene QPresident & CEOMay 27, 2015 Sale$12.8110,000128,100364,432May 28, 2015, 04:16 PM
Perkins Adelene QPresident & CEOMay 14, 2015 Sale$12.1810,000121,800374,432May 15, 2015, 04:28 PM
Palombella Vito J.Chief Scientific OfficerApr 30, 2015 Option Exercise$2.044,7379,6635,605May 01, 2015, 04:42 PM
Perkins Adelene QPresident & CEOMar 16, 2015 Sale$16.0020,000320,000384,432Mar 17, 2015, 05:40 PM
Perkins Adelene QPresident & CEOMar 05, 2015 Sale$16.5025,000412,500404,432Mar 09, 2015, 05:36 PM
Perkins Adelene QPresident & CEOJan 29, 2015 Sale$14.8320,000296,536429,432Mar 09, 2015, 05:34 PM
Perkins Adelene QPresident & CEOJan 29, 2015 Sale$14.8320,000296,536427,535Feb 02, 2015, 04:15 PM
Palombella Vito J.Chief Scientific OfficerDec 15, 2014 Option Exercise$2.044,7379,6634,737Dec 16, 2014, 07:44 PM
Palombella Vito J.Chief Scientific OfficerDec 15, 2014 Sale$16.324,73777,2940Dec 16, 2014, 07:44 PM
Palombella Vito J.Chief Scientific OfficerNov 26, 2014 Option Exercise$2.044,7369,6614,736Nov 28, 2014, 04:15 PM
Palombella Vito J.Chief Scientific OfficerNov 26, 2014 Sale$15.004,73671,0400Nov 28, 2014, 04:15 PM
EVNIN ANTHONY BDirectorOct 03, 2014 Option Exercise$12.5624,500307,76591,900Oct 06, 2014, 04:06 PM
EVNIN ANTHONY BDirectorSep 30, 2014 Sale$13.56112,4511,525,2290Oct 02, 2014, 04:05 PM
Palombella Vito J.Chief Scientific OfficerSep 03, 2014 Option Exercise$2.049,47219,3239,472Sep 05, 2014, 04:05 PM
Palombella Vito J.Chief Scientific OfficerSep 03, 2014 Sale$15.399,472145,7740Sep 05, 2014, 04:05 PM
Palombella Vito J.Chief Scientific OfficerJun 30, 2014 Option Exercise$10.838799,520879Jul 02, 2014, 06:20 PM
Palombella Vito J.Chief Scientific OfficerJul 01, 2014 Sale$12.8787911,3130Jul 02, 2014, 06:20 PM
SELBY NORMAN CDirectorMar 06, 2014 Option Exercise$8.872,50022,17510,000Mar 10, 2014, 05:26 PM
Palombella Vito J.Chief Scientific OfficerFeb 25, 2014 Option Exercise$2.044,7369,6614,736Feb 27, 2014, 04:05 PM
Palombella Vito J.Chief Scientific OfficerFeb 25, 2014 Sale$15.004,73671,0400Feb 27, 2014, 04:05 PM
Palombella Vito J.Chief Scientific OfficerDec 31, 2013 Option Exercise$11.747538,840753Jan 06, 2014, 04:30 PM
Palombella Vito J.Chief Scientific OfficerJan 02, 2014 Sale$13.5275310,1810Jan 06, 2014, 04:30 PM
EVNIN ANTHONY BDirectorDec 02, 2013 Sale$14.5617,756258,527112,451Dec 04, 2013, 04:30 PM
EVNIN ANTHONY BDirectorNov 27, 2013 Sale$14.561,20017,472130,207Nov 27, 2013, 04:40 PM
EVNIN ANTHONY BDirectorNov 26, 2013 Sale$14.72138,9612,045,506131,407Nov 27, 2013, 04:40 PM
EVNIN ANTHONY BDirectorNov 25, 2013 Sale$15.4023,703365,026270,368Nov 27, 2013, 04:40 PM
Palombella Vito J.Chief Scientific OfficerSep 27, 2013 Option Exercise$2.044,7369,6614,736Sep 30, 2013, 06:52 PM
Palombella Vito J.Chief Scientific OfficerSep 27, 2013 Sale$17.284,73681,8370Sep 30, 2013, 06:52 PM
Perkins Adelene QPres & Chief Executive OfficerSep 13, 2013 Sale$20.5013,076268,096447,535Sep 13, 2013, 06:00 PM
Perkins Adelene QPres & Chief Executive OfficerSep 12, 2013 Sale$20.8131,924664,390460,611Sep 13, 2013, 06:00 PM
Palombella Vito J.Chief Scientific OfficerJun 20, 2013 Option Exercise$1.7222,10338,01723,150Jun 21, 2013, 04:30 PM
Palombella Vito J.Chief Scientific OfficerJun 20, 2013 Sale$18.5323,150429,0670Jun 21, 2013, 04:30 PM
Beacon Co10% OwnerApr 16, 2013 Sale$38.405,708,282219,198,0380Apr 16, 2013, 04:13 PM
Rosebay Medical Co L.P.10% OwnerApr 16, 2013 Sale$38.405,708,283219,198,0760Apr 16, 2013, 04:12 PM
VENUTI MICHAEL CDirectorMar 06, 2013 Option Exercise$16.806,250105,00056,250Mar 07, 2013, 04:17 PM
SELBY NORMAN CDirectorDec 14, 2012 Option Exercise$8.872,50022,1757,500Dec 18, 2012, 04:31 PM
Perkins Adelene QPres & Chief Executive OfficerDec 07, 2012 Option Exercise$7.27175,9971,279,198492,535Dec 10, 2012, 07:05 PM
EVNIN ANTHONY BDirectorNov 29, 2012 Sale$24.624,832118,958294,071Nov 29, 2012, 04:12 PM
EVNIN ANTHONY BDirectorNov 27, 2012 Sale$25.2817,648446,171298,903Nov 29, 2012, 04:12 PM
EVNIN ANTHONY BDirectorNov 27, 2012 Option Exercise$6.9558,657407,72459,580Nov 28, 2012, 04:48 PM
Lindblom Christopher MSee RemarksNov 26, 2012 Option Exercise$13.0613,885181,37313,885Nov 27, 2012, 06:27 PM
Lindblom Christopher MSee RemarksNov 26, 2012 Sale$25.7313,885357,2720Nov 27, 2012, 06:27 PM
SELBY NORMAN CDirectorOct 15, 2012 Option Exercise$8.875,00044,3505,000Oct 16, 2012, 06:37 PM
Rosebay Medical Co L.P.10% OwnerSep 07, 2012 Buy$14.505,416,56578,540,1935,416,565Sep 11, 2012, 05:40 PM
Beacon Co10% OwnerSep 07, 2012 Buy$14.505,416,56578,540,1935,416,565Sep 11, 2012, 05:40 PM
Santabarbara PedroChief Medical OfficerSep 04, 2012 Option Exercise$6.509,20059,8009,200Sep 06, 2012, 04:10 PM
Holtzman Steven HDirectorMay 31, 2012 Sale$13.0157,573749,0250Jun 04, 2012, 05:23 PM
Holtzman Steven HDirectorMay 30, 2012 Sale$13.0010,958142,45457,573May 31, 2012, 05:58 PM
Holtzman Steven HDirectorMay 29, 2012 Sale$13.00189,3032,460,93968,531May 31, 2012, 05:58 PM
Perkins Adelene QPres & Chief Executive OfficerDec 16, 2010 Buy$6.1025,000152,569316,538Dec 17, 2010, 08:45 AM
Perkins Adelene QPres & Chief Executive OfficerAug 25, 2010 Buy$4.995,34926,692291,538Aug 26, 2010, 11:38 AM
Perkins Adelene QPres & Chief Executive OfficerAug 24, 2010 Buy$4.8944,651218,343286,189Aug 26, 2010, 11:38 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Perkins Adelene QDirector09/12/202328,714
Peluso StephaneChief Scientific Officer08/02/20229,932
EVNIN ANTHONY BDirector06/16/202231,491
SCHWARTZ BRIANDirector06/16/202220,994
BEIER DAVID WDirector06/10/202110,499
BVF PARTNERS L P/IL10% Owner02/11/202112,133,492
BVF PARTNERS L P/IL10% Owner01/22/202124,205,855
EVNIN ANTHONY BDirector06/13/201921,000
Berkowitz JeffreyDirector06/13/201942,000
BVF PARTNERS L P/IL10% Owner12/13/2018209,912
BVF PARTNERS L P/IL10% Owner11/28/2018130,000
BVF PARTNERS L P/IL10% Owner11/21/20186,345
BVF PARTNERS L P/IL10% Owner11/19/20182,005,076
BVF PARTNERS L P/IL10% Owner11/14/2018281,735
BVF PARTNERS L P/IL10% Owner11/13/2018815,681
BVF PARTNERS L P/IL10% Owner11/15/2018123,490
Perkins Adelene QChief Executive Officer10/01/201814,100
Kutok JefferyChief Scientific Officer08/16/201812,266
Kutok JefferyChief Scientific Officer08/15/201816,421
Kutok JefferyChief Scientific Officer06/22/201828,695
BVF PARTNERS L P/IL10% Owner06/19/20185,802,324
BVF PARTNERS L P/IL10% Owner06/21/2018702,126
Berkowitz JeffreyDirector06/12/201840,000
SMITH IAN FDirector06/12/201840,000
EVNIN ANTHONY BDirector06/12/201819,999
BEIER DAVID WDirector06/12/201810,000
BVF PARTNERS L P/IL10% Owner04/09/2018950,000
BVF PARTNERS L P/IL10% Owner04/10/20182,020,000
Perkins Adelene QChief Executive Officer03/05/201813,890
BLOCH LAWRENCE EPresident12/06/2017905,000
BVF PARTNERS L P/IL10% Owner10/04/2017839,029
BVF PARTNERS L P/IL10% Owner10/03/20171,169,047
Berkowitz JeffreyDirector05/25/201710,000
EVNIN ANTHONY BDirector05/25/201720,000
SMITH IAN FDirector05/25/201739,999
VENUTI MICHAEL CDirector03/17/201721,750
BVF PARTNERS L P/IL10% Owner01/03/20175,867
BVF PARTNERS L P/IL10% Owner12/30/20164,760
BVF PARTNERS L P/IL10% Owner12/28/2016986,805
BVF PARTNERS L P/IL10% Owner12/19/2016269,322
BVF PARTNERS L P/IL10% Owner12/16/2016556,360
BVF PARTNERS L P/IL10% Owner12/20/201629,809
KANGO SUJAYChief Commercial Officer12/13/201663,259
KANGO SUJAYChief Commercial Officer12/12/201632,612
BVF PARTNERS L P/IL10% Owner12/01/2016176,365
BVF PARTNERS L P/IL10% Owner12/02/201662,480
EVNIN ANTHONY BDirector06/17/201619,999
LANDER ERIC SDirector06/17/20169,999
Berkowitz JeffreyDirector06/17/201639,999
LANDER ERIC SDirector09/01/201517,492
EVNIN ANTHONY BDirector09/01/201517,492
Berkowitz JeffreyDirector09/01/201534,993
Perkins Adelene QPresident & CEO06/25/201554,650
Palombella Vito J.Chief Scientific Officer06/15/201551,965
Perkins Adelene QPresident & CEO05/27/2015128,100
Perkins Adelene QPresident & CEO05/14/2015121,800
Palombella Vito J.Chief Scientific Officer04/30/20159,663
Perkins Adelene QPresident & CEO03/16/2015320,000
Perkins Adelene QPresident & CEO03/05/2015412,500
Perkins Adelene QPresident & CEO01/29/2015296,536
Perkins Adelene QPresident & CEO01/29/2015296,536
Palombella Vito J.Chief Scientific Officer12/15/20149,663
Palombella Vito J.Chief Scientific Officer12/15/201477,294
Palombella Vito J.Chief Scientific Officer11/26/20149,661
Palombella Vito J.Chief Scientific Officer11/26/201471,040
EVNIN ANTHONY BDirector10/03/2014307,765
EVNIN ANTHONY BDirector09/30/20141,525,229
Palombella Vito J.Chief Scientific Officer09/03/201419,323
Palombella Vito J.Chief Scientific Officer09/03/2014145,774
Palombella Vito J.Chief Scientific Officer06/30/20149,520
Palombella Vito J.Chief Scientific Officer07/01/201411,313
SELBY NORMAN CDirector03/06/201422,175
Palombella Vito J.Chief Scientific Officer02/25/20149,661
Palombella Vito J.Chief Scientific Officer02/25/201471,040
Palombella Vito J.Chief Scientific Officer12/31/20138,840
Palombella Vito J.Chief Scientific Officer01/02/201410,181
EVNIN ANTHONY BDirector12/02/2013258,527
EVNIN ANTHONY BDirector11/27/201317,472
EVNIN ANTHONY BDirector11/26/20132,045,506
EVNIN ANTHONY BDirector11/25/2013365,026
Palombella Vito J.Chief Scientific Officer09/27/20139,661
Palombella Vito J.Chief Scientific Officer09/27/201381,837
Perkins Adelene QPres & Chief Executive Officer09/13/2013268,096
Perkins Adelene QPres & Chief Executive Officer09/12/2013664,390
Palombella Vito J.Chief Scientific Officer06/20/201338,017
Palombella Vito J.Chief Scientific Officer06/20/2013429,067
Beacon Co10% Owner04/16/2013219,198,038
Rosebay Medical Co L.P.10% Owner04/16/2013219,198,076
VENUTI MICHAEL CDirector03/06/2013105,000
SELBY NORMAN CDirector12/14/201222,175
Perkins Adelene QPres & Chief Executive Officer12/07/20121,279,198
EVNIN ANTHONY BDirector11/29/2012118,958
EVNIN ANTHONY BDirector11/27/2012446,171
EVNIN ANTHONY BDirector11/27/2012407,724
Lindblom Christopher MSee Remarks11/26/2012181,373
Lindblom Christopher MSee Remarks11/26/2012357,272
SELBY NORMAN CDirector10/15/201244,350
Rosebay Medical Co L.P.10% Owner09/07/201278,540,193
Beacon Co10% Owner09/07/201278,540,193
Santabarbara PedroChief Medical Officer09/04/201259,800
Holtzman Steven HDirector05/31/2012749,025
Holtzman Steven HDirector05/30/2012142,454
Holtzman Steven HDirector05/29/20122,460,939
Perkins Adelene QPres & Chief Executive Officer12/16/2010152,569
Perkins Adelene QPres & Chief Executive Officer08/25/201026,692
Perkins Adelene QPres & Chief Executive Officer08/24/2010218,343
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR INFINITY PHARMACEUTICALS INC.
STOCK BUYBACKS FOR INFINITY PHARMACEUTICALS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
0.53%
1Q
06/30/2023
12/31/2022
0.59%
2Q
06/30/2023
09/30/2022
0.55%
3Q
06/30/2023
06/30/2022
0.81%
4Q
06/30/2023
03/31/2022
0.82%
5Q
06/30/2023
12/31/2021
0.89%
6Q
06/30/2023
09/30/2021
1.26%
7Q
06/30/2023
06/30/2021
1.38%
8Q
06/30/2023
03/31/2021
18.69%
9Q
06/30/2023
12/31/2020
40.19%
10Q
06/30/2023
09/30/2020
48.56%
11Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
0.53%
1Q
12/31/2022
0.59%
2Q
09/30/2022
0.55%
3Q
06/30/2022
0.81%
4Q
03/31/2022
0.82%
5Q
12/31/2021
0.89%
6Q
09/30/2021
1.26%
7Q
06/30/2021
1.38%
8Q
03/31/2021
18.69%
9Q
12/31/2020
40.19%
10Q
09/30/2020
48.56%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INFINITY PHARMACEUTICALS INC.
LOADING...